Syndax Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$17.04(as of Sep 5, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Syndax Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$17.04
Ticker SymbolSNDX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees270
CountyUSA
Market Cap$1,389.5M
EBIDTA-339.0M
10-Day Moving Average16.09
P/E Ratio-4.17
20-Day Moving Average15.13
Forward P/E Ratio0.00
50-Day Moving Average11.90
Earnings per Share-3.89
200-Day Moving Average12.83
Profit Margin-189.28%
RSI72.62
Shares Outstanding86.1M
ATR0.77
52-Week High22.50
Volume1,442,346
52-Week Low8.58
Most Recent Support Level15.81
Book Value157.4M
Most Recent Resistance Level16.89
P/B Ratio8.88
Upper Keltner16.86
P/S Ratio17.88
Lower Keltner13.39
Debt-to-Equity Ratio16.86
Next Earnings Date11/11/2025
Cash Surplus-4.4M
Next Ex-Dividend DateUnknown

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

Syndax Pharmaceuticals Inc In Our Stock Scanner

As of Sep 05, 2025
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.